COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 2588: Articles 25871-25880  | Next

Nano short peptide nutrition intervention on the prognosis of patients with COVID-19
Zhang, Z. L. Z., Yang, L., Zhang, T. Z.
10.1101/2020.06.03.20083980 — Posted: 2020-06-08
Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution
Velu, P., Craney, A., Ruggiero, P., Sipley, J., Cong, L., Hissong, E., Loda, M., Westblade, L. F., Cushing, M., Rennert, H.
10.1101/2020.06.05.20109637 — Posted: 2020-06-08
The Current COVID-19 Spread Pattern in India
Baruah, H. K.
10.1101/2020.06.03.20121210 — Posted: 2020-06-08
Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia: Planned Day-7 Interim Analysis of a Registered Clinical Trial
Hess, C. B., Buchwald, Z. S., Stokes, W., Switchenko, J. M., Nasti, T. H., Weinberg, B. D., Steinberg, J. P., Goddette, K. D., Ahmed, R., Curran, W. J., Khan, M. K.
10.1101/2020.06.03.20116988 — Posted: 2020-06-08 Discussion: Onsite
Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype
Gaurav, S., Pandey, S., Puvar, A., Shah, T., Joshi, M., Joshi, C., Kumar, S.
10.1101/2020.06.06.137604 — Posted: 2020-06-07 Discussion: Onsite
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism
Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., Hosen, M. J.
10.1101/2020.06.07.138800 — Posted: 2020-06-07
Molecular mechanism of SARS-Cov-2 components caused ARDS in murine model
Gu, T., Zhao, S., Jin, G., Song, M., Zhi, Y., Zhao, R., Ma, F., Zheng, Y., Wang, K., Liu, H., Xin, M., Li, X., Dong, C. D., Liu, K., Dong, Z.
10.1101/2020.06.07.119032 — Posted: 2020-06-07
Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation
Inagaki, H., Saito, a., Sugiyama, H., Okabayashi, T., Fujimoto, S.
10.1101/2020.06.06.138149 — Posted: 2020-06-07
Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system
Cantuti-Castelvetri, L., Ohja, R., Pedro, L., Djannatian, M., Franz, J., Kuivanen, S., Kallio, K., Kaya, T., Anastasina, M., Smura, T., Levanov, L., Szirovicza, L., Tobi, A., Kallio-Kokko, H., Osterlund, P., Joensuu, M., Meunier, F., Butcher, S., Winkler, M., Mollenhauer, B., Helenius, A., Gokce, O., Teesalu, T., Hepojoki, J., Vapalahti, O., Stadelmann, C., Balistreri, G., Simons, M.
10.1101/2020.06.07.137802 — Posted: 2020-06-07 Discussion: Onsite | Offsite
Heart Disease Deaths during the Covid-19 Pandemic
Faust, J., Lin, Z., Krumholz, H.
10.1101/2020.06.04.20122317 — Posted: 2020-06-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).